Insulin as an effector of human ovarian and adrenal steroid metabolism

Endocrinology and Metabolism Clinics of North America

Volumn 20, Issue 4, 1991, Pages 807-823

  Nestler, J E ^a   Strauss III, J F ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; DIAZOXIDE; FOLLITROPIN; INSULIN; LEUPRORELIN; LUTEINIZING HORMONE; PRASTERONE SULFATE; TESTOSTERONE;

ADRENAL GLAND; CONTROLLED STUDY; FEMALE; HUMAN; OBESITY; ORAL DRUG ADMINISTRATION; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; REVIEW; STEROIDOGENESIS;

EID: 0026353647     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0889-8529(18)30245-7     Document Type: Review

References (93)

1. Abraham G.E. Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle J Clin Endocrinol Metab 39 1974 340
2. Adashi E.Y. Fabrics C. Hsueh A.J.W. Insulin augmentation of testosterone production in a primary culture of rat testicular cells Biol Reprod 26 1982 270
3. Barbieri R.L. Ryan K.J. Hyperandrogenism, insulin resistance, and acanthosis nigricans syndrome: A common endocrinopathy with distinct pathophysiologic features Am J Obstet Gynecol 147 1983 90
4. Barbieri R.L. Makris A. Randall R.W. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism J Clin Endocrinol Metab 62 1986 904
5. Barbieri R.L. Smith S. Ryan K.J. The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism Fertil Steril 50 1988 197
6. Barbieri R.L. Hornstein M.D. Hyperinsulinemia and ovarian hyperandrogenism. Cause and effect Endocrinol Metab Clin North Am 17 1988 685
7. Barnes R.B. Rosenfield R.L. Burstein S. Pituitary-ovarian responses to nafarelin in the polycystic ovary syndrome N Engl J Med 320 1989 559
8. Bates G.W. Whitworth N.S. Effect of body weight reduction on plasma androgens in obese, infertile women Fertil Steril 38 1982 406
9. Baxter R.C. Cowell C.T. Diurnal rhythm of growth hormone—independent binding protein for insulin-like growth factors in human plasma J Clin Endocrinol Metab 62 1987 432
10. Blanco F.L. Fanjul L.F. Ruiz de Galarreta C.M. The effect of insulin and luteinizing hormone treatment on serum concentrations of testosterone and dihydrotestosterone and testicular 3β-hydroxysteroid dehydrogenase activity in intact and hypophysectomized diabetic rats Endocrinology 109 1981 1248
11. Blay J. Hollenberg M.D. The nature and function of polypeptide growth factor receptors in the human placenta J Dev Physiol 12 1989 237
12. Burghen G.A. Givens J.R. Kitabchi A.E. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease J Clin Endocrinol Metab 50 1980 113
13. Cara J.F. Rosenfield R.L. Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells Endocrinology 123 1988 733
14. Cara J.F. Fan J. Azzarello J. Insulin-like growth factor-I enhances luteinizing hormone binding to rat ovarian theca-interstitial cells J Clin Invest 86 1990 560
15. Chang R.J. Nakaruma R.M. Judd H.L. Insulin resistance in nonobese patients with polycystic ovarian disease J Clin Endocrinol Metab 57 1983 356
16. Conover C.A. Lee P.D.K. Insulin regulation of insulin-like growth factor-binding protein production in cultured HepG2 cells J Clin Endocrinol Metab 70 1990 1062
17. Diamond M.P. Grainger D. Laudino A.J. Effect of acute physiological elevations of insulin on circulating androgen levels in nonobese women J Clin Endocrinol Metab 72 1991 883
18. Dunaif A. Mandeli J. Fluhr H. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome J Clin Endocrinol Metab 66 1988 131
19. Dunaif A. Graf M. Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin resistant women with the polycystic ovary syndrome J Clin Invest 83 1989 23
20. Dunaif A. Segal K.R. Futterweit W. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome Diabetes 38 1989 1165
21. Dunaif A. Green G. Futterweit W. Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome J Clin Endocrinol Metab 70 1990 699
22. Erickson G.F. Magoffin D.A. Cragun J.R. The effects of insulin and insulin-like growth factors-I and -II on estradiol production by granulosa cells of polycystic ovaries J Clin Endocrinol Metab 70 1990 894
23. Falcone T. Finegood D.T. Fantus G. Androgen response to endogenous insulin secretion during the frequently sampled intravenous glucose tolerance test in normal and hyperandrogenic women J Clin Endocrinol Metab 71 1990 1653
24. Farah M.J. Givens J.R. Kitabchi A.E. Bimodal correlation between the circulating insulin level and the production rate of dehydroepiandrosterone: Positive correlation in controls and negative correlation in the polycystic ovary syndrome with acanthosis nigricans J Clin Endocrinol Metab 70 1990 1075
25. Flier J.S. Eastman R.C. Minaker K.L. Acanthosis nigricans in obese women with hyperandrogenism. Characterization of an insulin-resistant state distinct from the Type A and B syndromes Diabetes 34 1985 101
26. Garzo V.G. Dorrington J.H. Aromatase activity in human granulosa cells during follicular development and the modulation of follicle-stimulating hormone and insulin Am J Obstet Gynecol 148 1984 657
27. Gates G.S. Bayer S. Seibel M. Characterization of insulin-like growth factor I binding to human granulosa cells obtained during in vitro fertilization J Recept Res 7 1987 885
28. Geffner M.E. Kaplan S.A. Bersch N. Persistence of insulin resistance in polycystic ovarian disease after inhibition of ovarian steroid secretion Fertil Steril 45 1986 327
29. Givens J.R. Familial polycystic ovarian disease Endocrinol Metab Clin North Am 17 1988 771
30. Grunberger G. Taylor S.I. Dons R.F. Insulin receptors in normal and disease states Clin Endocrinol Metab 12 1988 191
31. Gulati P. Skett P. The effect of the insulin mediator on the metabolism of androst-4-ene-3,17-dione in isolated rat hepatocytes Biochem Pharmacol 38 1989 4415
32. Haffner S.M. Katz M.S. Stern M.P. The relationship of sex hormones to hyperinsulinemia and hyperglycemia Metabolism 37 1988 683
33. Harlass F.E. Plymate S.R. Fariss B.L. Weight loss is associated with correction of gonadotropin and sex steroid abnormalities in the obese anovulatory female Fertil Steril 42 1984 649
34. Hernandez E.R. Resnick C.E. Svoboda M.E. Somatomedin-C/insulin-like growth factor I as an enhancer of androgen biosynthesis by cultured rat ovarian cells Endocrinology 122 1988 1603
35. Hubert GD, Schriock ED, Givens JR, et al: Insulin suppression of adrenal androgen concentrations during glucose tolerance testing in normal women [abstract 31]. In Scientific Program and Abstracts for the 37th Annual Meeting of the Society for Gynecologic Investigation, 1990, p 112
36. Hussin A.H. Skett P. The effect of insulin on steroid metabolism in isolated rat hepatocytes Biochem Pharmacol 36 1987 3155
37. Imperato-McGinley J. Peterson R.E. Sturla E. Primary amenorrhea associated with hirsutism, acanthosis nigricans, dermoid cysts of the ovaries and a new type of insulin resistance Am J Med 65 1978 389
38. Jarrett J.C. II Ballejo G. Tsibris J.C.M. Insulin binding to human ovaries J Clin Endocrinol Metab 60 1985 460
39. Kahn C.R. Flier J.S. Bar R.S. The syndrome of insulin resistance and acanthosis nigricans N Engl J Med 294 1976 739
40. Kiddy D.S. Sharp P.S. White D.M. Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: An analysis of 263 consecutive cases Clin Endocrinol (Oxf) 32 1990 213
41. Koistinen R. Suikkari A.-M. Tiitinen A. Human granulosa cells contain insulin-like growth factor-binding protein (IGF BP-1) mRNA Clin Endocrinol (Oxf) 32 1990 635
42. Kramer R.E. Buster J.E. Andersen R.N. Differential modulation of ACTH-stimulated cortisol and androstenedione secretion by insulin J Steroid Biochem 36 1990 33
43. Liu C.H. Laughlin G.A. Fischer U.G. Marked attenuation of ultradian and circadian rhythms of dehydroepiandrosterone in postmenopausal women: Evidence for a reduced 17,20-desmolase enzymatic activity J Clin Endocrinol Metab 71 1990 900
44. McClanahan M.A. Clore J.N. Blackard W.G. Insulin inhibits adrenal 17,20-lyase activity Clin Res 38 1990 979A
45. Micic D. Popovic V. Nesovic M. Androgen levels during sequential insulin euglycemic clamp studies in patients with polycystic ovary disease J Steroid Biochem 31 1988 995
46. Migeon C.J. Keller A.R. Lawrence B. Dehydroepiandrosterone and androsterone levels in human plasma. Effect of age and sex; day-to-day and diurnal variations J Clin Endocrinol Metab 17 1957 1051
47. Möller D.E. Flier J.S. Detection of an alteration in the insulin-receptor gene in a patient with insulin resistance, acanthosis nigricans, and the polycystic ovary syndrome (Type A insulin resistance) N Engl J Med 319 1988 1526
48. Morley P. Calaresu F.R. Barbe G.J. Insulin enhances luteinizing hormone-stimulated steroidogenesis by porcine theca cells Biol Reprod 40 1989 735
49. Nagamani M. Minh T.V. Kelver M.E. Hyperinsulinemia in hyperthecosis of the ovaries Am J Obstet Gynecol 154 1986 384
50. Nestler J.E. Modulation of aromatase and P450 cholesterol side-chain cleavage enzyme activities of human placental cytotrophoblasts by insulin and insulin-like growth factor I Endocrinology 121 1987 1845
51. Nestler J.E. Clore J.N. Strauss J.F. III The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans J Clin Endocrinol Metab 64 1987 180
52. Nestler J.E. Insulin and insulin-like growth factor I stimulate the 3β-hydroxysteroid dehydrogenase activity of human placental cytotrophoblasts Endocrinology 125 1989 2127
53. Nestler J.E. Clore J.N. Blackard W.G. The central role of obesity (hyperinsulinemia) in the pathogenesis of the polycystic ovary syndrome Am J Obstet Gynecol 161 1989 1095
54. Nestler J.E. Barlascini C.O. Matt D.W. Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome J Clin Endocrinol Metab 68 1989 1027
55. Nestler J.E. Usiskin K.S. Barlascini C.O. Suppression of serum dehydroepiandroster one sulfate levels by insulin: An evaluation of possible mechanisms J Clin Endocrinol Metab 69 1989 1040
56. Nestler J.E. Barlascini C.O. Tetrault G.A. Increased transcapillary escape rate of albumin in nondiabetic men in response to hyperinsulinemia Diabetes 39 1990 1212
57. Nestler J.E. Singh R. Matt D.W. Suppression of serum insulin by diazoxide does not alter serum testosterone or sex hormone-binding globulin levels in healthy nonobese women Am J Obstet Gynecol 163 1990 1243
58. Nestler J.E. Powers L.P. Matt D.W. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome J Clin Endocrinol Metab 72 1991 83
59. Nestler JE, Romero G, Huang LC, Zhang C, Larner J: Insulin mediators are the signal transduction system responsible for insulin’s actions on human placental steroidogenesis. Endocrinology 129: in press (December 1991)
60. Nissley S.P. Rechler M.M. Somatomedin/insulin-like growth factor tissue receptors Clin Endocrinol Metab 13 1984 43
61. Orentreich N. Brind J.L. Rizer R.L. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood J Clin Endocrinol Metab 59 1984 551
62. Pardridge W.M. Serum bioavailability of sex steroid hormones Clin Endocrinol Metab 15 1986 259
63. Parker L. Lifrak E. Shively J. Control of adrenal androgen secretion Lardy H. Stratman F. Hormones, Thermogenesis, and Obesity 1989 Elsevier New York 355
64. Pasquali R. Casimirri F. Venturoli S. Insulin resistance in patients with polycystic ovaries: Its relationship to body weight and androgen levels Acta Endocrinol (Copenh) 104 1983 110
65. Pasquali R. Fabbri R. Venturoli S. Effect of weight loss and antiandrogenic therapy on sex hormone blood levels and insulin resistance in obese patients with polycystic ovaries Am J Obstet Gynecol 154 1986 139
66. Peiris A.N. Sothmann M.S. Aiman E.J. The relationship of insulin to sex hormone binding globulin: Role of adiposity Fertil Steril 52 1989 69
67. Pekonen F. Laatikainen T. Buyalos R. Decreased 34K insulin-like growth factor binding protein in polycystic ovarian disease Fertil Steril 51 1989 972
68. Plymate S.R. Fariss B.L. Bassett M.L. Obesity and its role in polycystic ovary syndrome J Clin Endocrinol Metab 52 1981 1246
69. Plymate S.R. Matej L.A. Jones R.E. Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin J Clin Endocrinol Metab 67 1988 460
70. Poretsky L. Smith D. Seibel M. Specific insulin binding sites in human ovary J Clin Endocrinol Metab 59 1984 809
71. Poretsky L. Kalin M.F. The gonadotropic function of insulin Endocr Rev 8 1987 132
72. Poretsky L. Grigorescu F. Seibel M. Distribution and characterization of insulin and insulin-like growth factor I receptors in normal human ovary J Clin Endocrinol Metab 61 1985 728
73. Poretsky L. Bhargava G. Levitan E. Type I insulin-like growth factor receptors in human ovarian stroma Horm Res 33 1990 22
74. Poretsky L. Bhargava G. Saketos M. Regulation of human ovarian insulin receptors in vivo Metabolism 39 1990 161
75. Reed M.J. James V.H.T. Regulation of steroid synthesis and metabolism by growth factors Clin Endocrinol (Oxf) 31 1989 511
76. Richards G.E. Cavallo A. Meyer W.J. III Obesity, acanthosis nigricans, insulin resistance, and hyperandrogenemia: Pediatric perspective and natural history I Pediatr 107 1985 893
77. Rosenfield R.L. Barnes R.B. Cara J.F. Dysregulation of cyctochrome P450cl7a as the cause of polycystic ovary syndrome Fertil Steril 53 1990 785
78. Rowe J.W. Young J.B. Minaker K.L. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man Diabetes 30 1981 219
79. von Schoultz B. Carlström K. On the regulation of sex-hormone-binding globulin—a challenge of an old dogma and outlines of an alternative mechanism J Steroid Biochem 32 1989 327
80. Seppälä M. Wahlstrom T. Kosimies A.I. Human preovulatory follicular fluid, luteinized cells of hyperstimulated preovulatory follicles, and corpus luteum contain placental protein 12 J Clin Endocrinol Metab 58 1984 505
81. Shoupe D. Kumar D.D. Lobo R.A. Insulin resistance in polycystic ovary syndrome Am J Obstet Gynecol 147 1983 588
82. Shoupe D. Lobo R.A. The influence of androgens on insulin resistance Fertil Steril 41 1984 385
83. Smith S. Ravnikar V.A. Barbieri R.L. Androgen and insulin response to an oral glucose challenge in hyperandrogenic women Fertil Steril 48 1987 72
84. Stuart C.A. Peters E.I. Prince M.J. Insulin resistance with acanthosis nigricans: The roles of obesity and androgen excess Metabolism 35 1986 197
85. Stuart C.A. Prince N.J. Peters E.J. Hyperinsulinemia and hyperandrogenemia: in vivo response to insulin infusion Obstet Gynecol 69 1987 921
86. Suikkari A.-M. Koivisto V.A. Rutanen E.-M. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein J Clin Endocrinol Metab 66 1988 266
87. Suikkari A.-M. Ruutiainen K. Erkkola R. Low levels of low molecular weight insulin-like growth factor-binding protein in patients with polycystic ovarian disease Hum Reprod 4 1989 136
88. Taylor S.I. Dons R.F. Hernandez E. Insulin resistance associated with androgen excess in women with autoantibodies to the insulin receptor Ann Intern Med 97 1982 851
89. Veldhuis J.D. Kolp L.A. Toaff M.E. Mechanisms subserving the trophic actions of insulin on ovarian cells J Clin Invest 72 1983 1046
90. Veldhuis J.D. Nestler J.E. Strauss J.F. III Insulin regulates low-density lipoprotein binding and degradation by swine granulosa cells Endocrinology 118 1986 2242
91. Veldhuis J.D. Rodgers R.J. Dee A. The insulin-like growth factor, somatomedin C, induces the synthesis of cholesterol side-chain cleavage cytochrome P-450 and adrenodoxin in ovarian cells J Biol Chem 261 1986 2499
92. Yen S.C.C. The polycystic ovary syndrome Clin Endocrinol (Oxf) 12 1980 177
93. Yoshimasa Y. Seino S. Whittaker J. Insulin-resistant diabetes due to a point mutation that prevents insulin proreceptor processing Science 240 1988 784